Vaccines for counteracting inhibition of neutrophil degranulation
US4701323A · kind A · utility
2Cited by
3References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 23, 1985 |
| Grant date | Oct 20, 1987 |
| Priority date | — |
| Expiry date | Oct 23, 2005 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/6081
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Vaccines for counteracting inhibition of neutrophil degranulation by pathogenic cellular microorganisms comprise one or more purines conjugated to antigenic carriers. The purines include adenine and/or guanine in the form of a base, nucleoside, or nucleotide. The vaccines can be used with cattle to increase resistance to infections by Brucella abortus (brucellosis) and/or Haemophilus somnus (thromboembolic meningoencephalitis) and related symptomatic complex.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.